BRPI0815035A2 - Método para tratar um estado de doença pulmonar em mamíferos. - Google Patents

Método para tratar um estado de doença pulmonar em mamíferos.

Info

Publication number: BRPI0815035A2
Authority: BR; Brazil
Prior art keywords: mammals; treating; disease state; lung disease; lung
Prior art date: 2007-08-08

Application number

BRPI0815035-4A2A

Other languages

English (en)

Inventor

Alain Martin

Original Assignee

Cellular Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-08

Filing date

2008-08-04

Publication date

2014-09-30

2007-08-08 Priority claimed from US11/890,911 external-priority patent/US8114907B2/en

2008-08-04 Application filed by Cellular Sciences Inc filed Critical Cellular Sciences Inc

2014-09-30 Publication of BRPI0815035A2 publication Critical patent/BRPI0815035A2/pt

Links

208000019693 Lung disease Diseases 0.000 title 1
241000124008 Mammalia Species 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Oncology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0815035-4A2A 2007-08-08 2008-08-04 Método para tratar um estado de doença pulmonar em mamíferos. BRPI0815035A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/890,911 US8114907B2 (en)	2007-08-08	2007-08-08	Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
US12/009,649 US8211943B2 (en)	2007-08-08	2008-01-22	Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
PCT/US2008/009371 WO2009020582A1 (en)	2007-08-08	2008-08-04	Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells

Publications (1)

Publication Number	Publication Date
BRPI0815035A2 true BRPI0815035A2 (pt)	2014-09-30

Family

ID=40341582

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0815035-4A2A BRPI0815035A2 (pt)	2007-08-08	2008-08-04	Método para tratar um estado de doença pulmonar em mamíferos.

Country Status (8)

Country	Link
US (1)	US8211943B2 (pt)
EP (1)	EP2187738A4 (pt)
CN (2)	CN105832715B (pt)
BR (1)	BRPI0815035A2 (pt)
CA (1)	CA2694140A1 (pt)
MX (1)	MX2010000747A (pt)
TW (1)	TW200924741A (pt)
WO (1)	WO2009020582A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9675569B2 (en) *	2007-08-08	2017-06-13	Alain Martin	Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
WO2013187891A1 (en) *	2012-06-13	2013-12-19	Alain Martin	Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
CN104027346B (zh) *	2013-11-28	2017-01-18	江苏长泰药业有限公司	一种治疗伤口溃烂的药物组合物及其制备方法
CN103610671A (zh) *	2013-12-10	2014-03-05	江苏长泰药业有限公司	丙酮酸药物组成及其在制备治疗肺癌药物中的用途
US20200237815A1 (en) *	2017-02-24	2020-07-30	Alain Martin	Methods for treatment of lung damage and for inhibition of lung fibrosis
US11311505B2 (en) *	2017-02-24	2022-04-26	Cellular Sciences, Inc.	Synergistic compositions to stimulate the synthesis of human lung and sinus surfactants to decrease coughing, increase FEV-1/FVC ratios, decrease lung fibrosis, by increasing apoptosis of myofibroblasts
US20180338936A1 (en) *	2017-05-23	2018-11-29	Alain Martin	Methods and Compositions for the Treatment and Prevention of Allergic Rhinitis
WO2020185654A1 (en)	2019-03-08	2020-09-17	Colgate-Palmolive Company	Personal care compositions
US11331253B2 (en)	2019-11-14	2022-05-17	Colgate-Palmolive Company	Personal care compositions for treating odor causing bacteria and methods for the same
AU2021235937B2 (en) *	2020-03-09	2023-12-07	Colgate-Palmolive Company	Personal care compositions
CN113368219B (zh) *	2021-06-28	2024-05-10	广东工业大学	Globulol的应用
MX2024002382A (es)	2021-09-01	2024-03-14	Colgate Palmolive Co	Composiciones para el cuidado personal que contienen mezclas posbioticas para reequilibrar el microbioma de la piel.
EP4376800A1 (en)	2021-09-03	2024-06-05	Colgate-Palmolive Company	Personal care compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5798388A (en) *	1996-09-06	1998-08-25	Cellular Sciences, Inc.	Method and composition for treating mammalian diseases caused by inflammatory response
EP1379230A4 (en) *	2001-03-15	2009-01-21	Univ Pittsburgh	METHOD OF USE OF PYRUVATE AND / OR ITS DERIVATIVES FOR TREATING CYTOKINE-ORGANIZED INFLAMMABLE CONDITIONS
US6689810B2 (en) *	2001-08-21	2004-02-10	Cellular Sciences, Inc.	Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
US20050152905A1 (en) *	2002-08-22	2005-07-14	Omoigui Osemwota S.	Method of biochemical treatment of persistent pain

2008
- 2008-01-22 US US12/009,649 patent/US8211943B2/en active Active - Reinstated
- 2008-08-04 MX MX2010000747A patent/MX2010000747A/es active IP Right Grant
- 2008-08-04 BR BRPI0815035-4A2A patent/BRPI0815035A2/pt not_active IP Right Cessation
- 2008-08-04 EP EP08795015A patent/EP2187738A4/en not_active Withdrawn
- 2008-08-04 WO PCT/US2008/009371 patent/WO2009020582A1/en not_active Ceased
- 2008-08-04 CA CA2694140A patent/CA2694140A1/en not_active Abandoned
- 2008-08-04 CN CN201610158229.7A patent/CN105832715B/zh not_active Expired - Fee Related
- 2008-08-04 CN CN200880102471.6A patent/CN101820753B/zh not_active Expired - Fee Related
- 2008-08-07 TW TW097129972A patent/TW200924741A/zh unknown

Also Published As

Publication number	Publication date
CN101820753B (zh)	2016-04-13
MX2010000747A (es)	2010-07-05
CN101820753A (zh)	2010-09-01
WO2009020582A1 (en)	2009-02-12
US8211943B2 (en)	2012-07-03
EP2187738A1 (en)	2010-05-26
CA2694140A1 (en)	2009-02-12
CN105832715A (zh)	2016-08-10
CN105832715B (zh)	2018-09-04
EP2187738A4 (en)	2012-05-02
US20090041739A1 (en)	2009-02-12
TW200924741A (en)	2009-06-16

Legal Events

Date	Code	Title	Description
2017-10-24	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-29	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 10A ANUIDADE.
2018-09-11	B08G	Application fees: restoration [chapter 8.7 patent gazette]
2019-05-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2020-05-12	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-10-20	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 12A ANUIDADE.
2020-11-10	B08G	Application fees: restoration [chapter 8.7 patent gazette]
2020-11-24	B09B	Patent application refused [chapter 9.2 patent gazette]
2021-02-02	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2023-05-30	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 15A ANUIDADE.
2023-09-19	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2734 DE 30-05-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0815035A2 (pt)	2014-09-30	Método para tratar um estado de doença pulmonar em mamíferos.
BRPI0817664A2 (pt)	2015-03-24	Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
BRPI0814466A2 (pt)	2015-01-20	Método.
BRPI0821729A2 (pt)	2015-06-16	Tapete, revestimento de tapete e método para fabricar um tapete
NL2003118A1 (nl)	2010-01-18	Alignment system, lithographic system and method.
BRPI0919081A2 (pt)	2015-12-15	prepeg perfurado, método para formar um compósito reforçado com fibra, comósito, método para fabricar um prepeg perfurado, e, assentamento de prepeg ferfurado.
MX289945B (es)	2011-09-05	Fitasa de hafnia.
NL1034256A1 (nl)	2008-02-19	Spectroscopiesysteem.
BRPI0817394A2 (pt)	2015-03-31	Método para processamento de pozzolans
DE602007000924D1 (de)	2009-06-04	Schlüsselloses Zugangssystem
DE602007008655D1 (de)	2010-10-07	Schlüsselloses Zugangssystem
BRPI0812096A2 (pt)	2014-11-25	Máquina para pegar e armazenar preendedores de trilho de uma linha férrea, e método.
BRPI0811786A2 (pt)	2014-11-11	Acionador para inalador dosimetrado
BRPI0818888A2 (pt)	2014-11-04	Métodos para a produção de n-butanol.
BRPI0815796A2 (pt)	2015-02-18	Compósito elastomérico e método para produzi-lo.
BRPI0812459A2 (pt)	2014-12-02	" método para o processamento de areia de moldagem ".
PT1881104E (pt)	2014-03-25	Método para impressão digital em artigos têxteis
BRPI0718324A2 (pt)	2013-11-26	Métodos para o tratamento de depressão.
BRPI0813366A2 (pt)	2014-12-30	Método para executar uma combustão.
PT2001294T (pt)	2017-01-13	Método para combater fungos fitopatogénicos
BRPI0823029A2 (pt)	2015-07-28	Conjunto, e, método para fazer um conjunto.
BR112012004332A2 (pt)	2016-03-15	composição de limpeza, e, método para aumentar brilho em uma superfície.
BRPI0812254A2 (pt)	2015-07-14	Confirmação de identidade
ES1065187Y (es)	2008-02-16	Rodapie integrado en paredes, en particular para paredes constituidas o revestidas de carton-yeso
NL1036308A1 (nl)	2009-06-22	Lithographic method.